• Health & Medicine
• For Supporters

Professor Ian Tomlinson: “Philanthropy is priceless to science”

The director of our Cancer Research UK Edinburgh Centre walks us through some of his proudest research achievements and how supporters have made them possible. The director of our Cancer Research UK Edinburgh Centre walks us through some of his proudest research achievements and how supporters have made them possible.

3 June 2021

• For Researchers

A bug in the system – the difficulties of linking the microbiome to cancer aetiology

Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome. Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome.

2 June 2021

• Health & Medicine

Common anti-inflammatory drug could boost cancer immunotherapy

Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery. Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.

26 May 2021

• Policy & Insight

Opinion: ‘The UK must be more ambitious than just clearing the cancer backlog’

Despite staff working flat out, the pandemic has been devastating for NHS cancer services, writes Cancer Research UK's chief clinician. Despite staff working flat out, the pandemic has been devastating for NHS cancer services, writes Cancer Research UK's chief clinician.

24 May 2021

• For Supporters

Partnership in a pandemic: how Credit Suisse delivered an incredible Charity of the Year partnership despite lockdown

We explore how our partner, Credit Suisse, adapted to significant changes in the fundraising environment to exceed its original targets for the partnership. We explore how our partner, Credit Suisse, adapted to significant changes in the fundraising environment to exceed its original targets for the partnership.

20 May 2021

• For Researchers

Cancer clinical trials – learning lessons from the COVID-19 pandemic

After a very difficult year for cancer clinical trials, we look to the future and ask what positive lessons can be learnt After a very difficult year for cancer clinical trials, we look to the future and ask what positive lessons can be learnt

20 May 2021

• Science & Technology

Scientists find cells in centre of tumours are most likely to spread

The new findings shed light on how cancer cells found in different parts of a tumour behave differently. The new findings shed light on how cancer cells found in different parts of a tumour behave differently.

19 May 2021

• For Supporters

Peer-to-peer match-funding initiative raises over £4 million for cancer research

The Cancer Research UK Challenge Fund, which we launched in the initial throes of the pandemic, will help to ensure we can continue funding vital research. The Cancer Research UK Challenge Fund, which we launched in the initial throes of the pandemic, will help to ensure we can continue funding vital research.

19 May 2021

• Health & Medicine

Research shows one size doesn’t fit all for cervical screening in the trans and non-binary community

Dr Alison Berner and team asked 140 trans men and non-binary people to share their past experiences and attitudes towards cervical screening. Dr Alison Berner and team asked 140 trans men and non-binary people to share their past experiences and attitudes towards cervical screening.

18 May 2021

• For Supporters

Catch up on Behind the Science 2021 – From funding stream to blood stream: Is drug development moving fast enough?

This year’s event took place virtually on Wednesday 12 May. Watch or listen back now. This year’s event took place virtually on Wednesday 12 May. Watch or listen back now.

18 May 2021

• Health & Medicine

Cancer Research UK spin-out goes public, ready to invest more in precision T cell therapies

Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO). Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).

18 May 2021

• Health & Medicine

One year on: How has COVID-19 affected cancer services?

Disruption to cancer screening, diagnosis and treatment has led to more than 45,000 fewer people starting cancer treatment between March 2020 and March 2021. Disruption to cancer screening, diagnosis and treatment has led to more than 45,000 fewer people starting cancer treatment between March 2020 and March 2021.

14 May 2021